Deepali is Senior Manager, Policy at Gavi. Her work includes the design of Gavi’s funding model and the identification of high value vaccine investments. In her 6 years at Gavi, Deepali developed Gavi’s market-shaping strategy for 2016-2020 and co-led the Vaccine Investment Strategy in 2018. She is the policy and programme lead on malaria vaccines, including developing an investment case for the Gavi Alliance Board to consider in December 2021. Prior to Gavi, she worked at the National Academies of Medicine in the US and was a Fulbright Scholar in Mongolia. She has an MPH from Johns Hopkins School of Public Health and a BS from Georgetown University.
Concordia Announces the Inaugural Washington, D.C. Forum
On September 16, 2026, leaders from government, business, civil society, and academia will convene for the inaugural Concordia Washington, D.C. Forum, a new gathering built to explore the geopolitical, economic, and strategic developments shaping
